ZS04
/ Zensun
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 26, 2025
An Ultrapotent Neutralizing Antibody Protected Non-Human Primates from Severe Fever with Thrombocytopenia Syndrome Virus Infection
(IMMUNOLOGY 2025)
- " Here, from SFTSV convalescent donors, we discovered an ultrapotent NAb ZS004-1C5 with subnanomolar neutralization titers (IC50=0.3 ng/mL)... Our findings provided proof-of-concept data to support clinical development of this antibody for SFTSV therapy, and discovered a novel neutralizing epitope that could benefit future vaccine design works.Keywords: Animals Non-Human Primate; Cells B Cells; Infections Viral; Molecules Antibodies; Tissues Spleen and Lymph Nodes"
Hematological Disorders • Infectious Disease • Inflammation • Thrombocytopenia • STAT1
September 01, 2024
Characterization of a ST137 multidrug-resistant Campylobacter jejuni strain with a tet(O)-positive genomic island from a bloodstream infection patient.
(PubMed, Microb Pathog)
- "LZCJ was resistant to norfloxacin, ampicillin, ceftriaxone, ciprofloxacin and tetracycline. This strain possessed a tet(O)-positive genomic island GI_LZCJ, which was closed to duck-derived C. jejuni ZS004, but with an additional ISChh1-like sequence. The above data indicated that the LZCJ strain may originate from foodborne bacteria on animals and the importance of continuous surveillance for the spread of foodborne bacteria."
Journal • Gastroenterology • Gastrointestinal Disorder • Infectious Disease • Oncology
1 to 2
Of
2
Go to page
1